1. Home
  2. ICUI vs NEA Comparison

ICUI vs NEA Comparison

Compare ICUI & NEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • NEA
  • Stock Information
  • Founded
  • ICUI 1984
  • NEA 2002
  • Country
  • ICUI United States
  • NEA United States
  • Employees
  • ICUI N/A
  • NEA N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • NEA Finance/Investors Services
  • Sector
  • ICUI Health Care
  • NEA Finance
  • Exchange
  • ICUI Nasdaq
  • NEA Nasdaq
  • Market Cap
  • ICUI 3.8B
  • NEA 3.3B
  • IPO Year
  • ICUI 1992
  • NEA N/A
  • Fundamental
  • Price
  • ICUI $141.97
  • NEA $11.45
  • Analyst Decision
  • ICUI Buy
  • NEA
  • Analyst Count
  • ICUI 4
  • NEA 0
  • Target Price
  • ICUI $199.67
  • NEA N/A
  • AVG Volume (30 Days)
  • ICUI 237.9K
  • NEA 803.4K
  • Earning Date
  • ICUI 05-06-2025
  • NEA 01-01-0001
  • Dividend Yield
  • ICUI N/A
  • NEA 4.23%
  • EPS Growth
  • ICUI N/A
  • NEA N/A
  • EPS
  • ICUI N/A
  • NEA N/A
  • Revenue
  • ICUI $2,382,046,000.00
  • NEA N/A
  • Revenue This Year
  • ICUI N/A
  • NEA N/A
  • Revenue Next Year
  • ICUI $3.00
  • NEA N/A
  • P/E Ratio
  • ICUI N/A
  • NEA N/A
  • Revenue Growth
  • ICUI 5.44
  • NEA N/A
  • 52 Week Low
  • ICUI $93.36
  • NEA $9.20
  • 52 Week High
  • ICUI $196.26
  • NEA $11.37
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 31.62
  • NEA 42.81
  • Support Level
  • ICUI $135.77
  • NEA $11.55
  • Resistance Level
  • ICUI $145.58
  • NEA $11.63
  • Average True Range (ATR)
  • ICUI 7.07
  • NEA 0.06
  • MACD
  • ICUI -1.55
  • NEA -0.02
  • Stochastic Oscillator
  • ICUI 21.09
  • NEA 9.48

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About NEA Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01

Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities.

Share on Social Networks: